106 related articles for article (PubMed ID: 15600005)
1. Clinical trial design in oncology: assessment of outcomes.
Gebski V
Lancet Oncol; 2004 Dec; 5(12):761-3. PubMed ID: 15600005
[No Abstract] [Full Text] [Related]
2. N-of-1 trials in oncology.
Collette L; Tombal B
Lancet Oncol; 2015 Aug; 16(8):885-6. PubMed ID: 26248830
[No Abstract] [Full Text] [Related]
3. Quality-of-life outcomes in oncology.
Siddiqui F; Kachnic LA; Movsas B
Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Khan OA; Tselis A; Boster A
Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
[No Abstract] [Full Text] [Related]
5. Pathology is a necessary and informative tool in oncology clinical trials.
Nagtegaal ID; West NP; van Krieken JH; Quirke P
J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial design in oncology: protocol design.
Sullivan R
Lancet Oncol; 2004 Dec; 5(12):759. PubMed ID: 15581549
[No Abstract] [Full Text] [Related]
7. [Health related quality of life and endpoints in oncology].
Bonnetain F
Cancer Radiother; 2010 Oct; 14(6-7):515-8. PubMed ID: 20674446
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial design in oncology: statistical power.
Gallo C; Perrone F
Lancet Oncol; 2004 Dec; 5(12):760-1. PubMed ID: 15600004
[No Abstract] [Full Text] [Related]
9. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
Booth CM
Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
[TBL] [Abstract][Full Text] [Related]
10. [Conducting a cost-effectiveness trial in oncology: justification and method].
Lejeune C; Binquet C; Bonnetain F
Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
[TBL] [Abstract][Full Text] [Related]
11. A three-outcome design for randomized comparative phase II clinical trials.
Hong S; Wang Y
Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
Teramukai S; Daimon T; Zohar S
Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
[TBL] [Abstract][Full Text] [Related]
13. Dealing with multiple endpoints.
Dueck A; Novotny PJ
Curr Probl Cancer; 2006; 30(6):298-306. PubMed ID: 17123881
[No Abstract] [Full Text] [Related]
14. Data handling in cancer clinical trials-how we can minimize potential biases.
Sakamoto J; Teramukai S
Jpn J Clin Oncol; 2002 Jan; 32(1):1-2. PubMed ID: 11932354
[No Abstract] [Full Text] [Related]
15. Testing of evaluation bias for progression free survival endpoint in oncology clinical trials.
Sun Y; Wu W; Sargent D
Stat Med; 2016 Sep; 35(22):3923-32. PubMed ID: 27089832
[TBL] [Abstract][Full Text] [Related]
16. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
17. Translating clinical trials into meaningful outcomes.
LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W
Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247
[TBL] [Abstract][Full Text] [Related]
18. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Karrison TG; Maitland ML; Stadler WM; Ratain MJ
J Natl Cancer Inst; 2007 Oct; 99(19):1455-61. PubMed ID: 17895472
[TBL] [Abstract][Full Text] [Related]
19. Early average change in tumor size in a phase 2 trial: efficient endpoint or false promise?
Rubinstein LV; Dancey JE; Korn EL; Smith MA; Wright JJ
J Natl Cancer Inst; 2007 Oct; 99(19):1422-3. PubMed ID: 17895470
[No Abstract] [Full Text] [Related]
20. Endpoints for clinical trials and revised assessment in neuro-oncology.
Butowski N; Chang SM
Curr Opin Neurol; 2012 Dec; 25(6):780-5. PubMed ID: 23007010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
